BRADLEY PHARMACEUTICALS INC
4, 2000-09-07
PHARMACEUTICAL PREPARATIONS
Previous: BRADLEY PHARMACEUTICALS INC, 4, 2000-09-07
Next: BRADLEY PHARMACEUTICALS INC, 4, 2000-09-07



__X__Check this box if no longer subject to Section 16. Form 4 or Form 5
     obligations may continue. See Instruction 1(b).

                      U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, D.C. 20549

                                     FORM 4

                    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange act of 1934,
Section 17(a) of the Public Utility Holding Company act of 1935 or
Section 30(f) of the Investment Company Act of 1940

1. Name and Address of Reporting Person
   Hillman   David      H.
   (Last)   (First)  (Middle)
   383 Route 46 West
       (Street)
   Fairfield     NJ    07004
     (City)   (State)  (Zip)
2. Issuer Name and Ticker or Trading Symbol       "BPRX"

   BRADLEY PHARMACEUTICALS, INC.

3. IRS or Social Security Number of Reporting Person (Voluntary)

4. Statement for Month/Year                       08/2000

5. If Amendment, Date of Original (Month/Year)

6. Relationship of Reporting Person to Issuer (Check all applicable)

   _____Director                             _____10 % Owner
   _____Officer (give title below)           __X__Other (specify below)


                       Former Secretary & Director

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially
          Owned
1. Title of Security (Instr.3)
   (1)   Class B Common Stock
   (2)   Common Stock
   (3)   Common Stock
   (4)   Common Stock
2. Transaction Date (Month/Day/Year)
   (1)   08/01/00
   (2)
   (3)
   (4)   08/01/00
3. Transaction Code (Instr.8)
   (1)   Code K
   (2)
   (3)
   (4)   Code K
4. Securities Acquired (A) or Disposed of (D) (Instr.3,4 and 5)
   (1)   Amount - 43,610 (D)  	Price - Swap for Common Stock
   (2)
   (3)
   (4)   Amount - 43,610 (A)  	Price - Swap from Class B
5. Amount of Securities Beneficially Owned at End of Month (Instr.3 and 4)
   (1)      -
   (2)    2,300
   (3)    1,780
   (4)   47,785
6. Ownership Form: Direct (D) or Indirect (I)
   (1)   (D)
   (2)   (D)
   (3)   (I)
   (4)   (D)
7. Nature of Indirect Beneficial Ownership (Instr.4)
   (1)
   (2)   With Spouse
   (3)   By IRA
   (4)

Reminder: Report on a separate line for each class of securities beneficially
          owned directly or indirectly.
                                 (Print or Type Responses)

FORM 4 (continued)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
           (e.g., puts, calls, warrants, options, convertible securities)

1.  Title of Derivative Security (Instr.3)
    (1)   Options (right to buy)
    (2)   Options (right to buy)
    (3)   Options (right to buy)
    (4)   Options (right to buy)
    (5)   Options (right to buy)
    (6)   Options (right to buy)
    (7)   Options (right to buy)
    (8)   Options (right to buy)
    (9)   Options (right to buy)
    (10)  Options (right to buy)
    (11)  Options (right to buy)
    (12)  Options (right to buy)
    (13)  Options (right to buy)
    (14)  Warrants (right to buy)
2.  Conversion or Exercise Price of Derivative Security
    (1)   1.46875
    (2)   1.46875
    (3)   1.46875
    (4)   1.18750
    (5)   1.46875
    (6)   1.46875
    (7)   1.46875
    (8)   1.99375
    (9)   1.99375
    (10)  1.99375
    (11)  1.99375
    (12)  1.99375
    (13)  1.99375
    (14)  2.37500
3.  Transaction Date (Month/Day/Year)
    (1)
    (2)
    (3)
    (4)
    (5)
    (6)
    (7)
    (8)
    (9)
    (10)
    (11)
    (12)
    (13)
    (14)  08/01/00
4.  Transaction Code (Instr.8)
    (1)
    (2)
    (3)
    (4)
    (5)
    (6)
    (7)
    (8)
    (9)
    (10)
    (11)
    (12)
    (13)
    (14)  Code A
5.  Number of Derivative Securities Acquired (A) or Disposed of (D)
    (Instr.3,4 and 5)
    (1)
    (2)
    (3)
    (4)
    (5)
    (6)
    (7)
    (8)
    (9)
    (10)
    (11)
    (12)
    (13)
    (14)  Amount - 32,766 (A)  	Price - 2.37500
6.  Date Exercisable and Expiration Date (Month/Day/Year)
    (1)   Exercisable - 04/12/95   Expiration - 04/11/04
    (2)   Exercisable - 04/12/96   Expiration - 04/11/04
    (3)   Exercisable - 04/12/97   Expiration - 04/11/04
    (4)   Exercisable - 01/05/96   Expiration - 01/04/06
    (5)   Exercisable - 12/30/95   Expiration - 12/29/04
    (6)   Exercisable - 12/30/96   Expiration - 12/29/04
    (7)   Exercisable - 12/30/97   Expiration - 12/29/04
    (8)   Exercisable - 01/27/99   Expiration - 01/26/08
    (9)   Exercisable - 01/27/00   Expiration - 01/26/08
    (10)  Exercisable - 01/27/01   Expiration - 01/26/08
    (11)  Exercisable - 01/27/99   Expiration - 01/26/03
    (12)  Exercisable - 01/27/00   Expiration - 01/26/03
    (13)  Exercisable - 01/27/01   Expiration - 01/26/03
    (14)  Exercisable - 08/01/00   Expiration - 07/31/03
7.  Title and Amount of Underlying Securities
    (1)   Title - Common Stock     Number of Shares -  2,000
    (2)   Title - Common Stock     Number of Shares -  2,000
    (3)   Title - Common Stock     Number of Shares -  2,000
    (4)   Title - Common Stock     Number of Shares - 53,568
    (5)   Title - Common Stock     Number of Shares -  2,000
    (6)   Title - Common Stock     Number of Shares -  2,000
    (7)   Title - Common Stock     Number of Shares -  2,000
    (8)   Title - Common Stock     Number of Shares -  2,333
    (9)   Title - Common Stock     Number of Shares -  2,333
    (10)  Title - Common Stock     Number of Shares -  2,334
    (11)  Title - Common Stock     Number of Shares -  3,250
    (12)  Title - Common Stock     Number of Shares -  3,250
    (13)  Title - Common Stock     Number of Shares -  3,250
    (14)  Title - Common Stock     Number of Shares - 32,766
8.  Price of Derivative Security (Instr.5)
    (1)   1.46875
    (2)   1.46875
    (3)   1.46875
    (4)   1.18750
    (5)   1.46875
    (6)   1.46875
    (7)   1.46875
    (8)   1.99375
    (9)   1.99375
    (10)  1.99375
    (11)  1.99375
    (12)  1.99375
    (13)  1.99375
    (14)  2.37500
9.  Number of Derivative Securities Beneficially Owned at End of Month
    (Instr.4)
    (1)    2,000
    (2)    2,000
    (3)    2,000
    (4)   53,568
    (5)    2,000
    (6)    2,000
    (7)    2,000
    (8)    2,333
    (9)    2,333
    (10)   2,334
    (11)   3,250
    (12)   3,250
    (13)   3,250
    (14)  32,766
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
    (Instr.4)
    (D)
11. Nature of Indirect Beneficial Ownership (Instr.4)

Explanation of Responses:




                                  /s/David H. Hillman      September 8, 2000
                           ------------------------------- -----------------
                           **Signature of Reporting Person        Date

** Intentional misstatements or omissions of facts constitute Federal Criminal
   Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed.
      If space provided is insufficient, see Instruction 6 for procedure.

                                                              SEC 1474 (3/91)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission